Search

A study conducted at the City of Hope National Medical Center in California found that older adults with cancer who experience elevated depression symptoms are at a higher risk for severe chemotherapy toxicity. However, this risk can be reduced through geriatric assessment-driven interventions. The study included 605 patients aged 65 and older with any stage of solid malignancy. Patients in the intervention arm received recommendations from a multidisciplinary team based on their baseline assessment, while those in the standard-of-care arm only received the baseline assessment results. The study suggests that addressing depression symptoms may lower the risk of toxicities in older adults with cancer. [Extracted from the article]

The article suggests that individuals aged 50 or older with clinically apparent Helicobacter pylori infection (CAHPI) may have an 11 percent increased risk for Alzheimer's disease (AD), according to a large population-based study. Topics include the methodology of the study, the association between CAHPI and AD risk, and the potential implications for future interventions.

The article focuses on a randomized controlled trial that suggests over-the-scope clips (OTSC) may be more effective than standard endoscopic treatment in preventing further bleeding in high-risk nonvariceal upper gastrointestinal lesions. However, reservations remain about the routine first-line use of OTSCs due to concerns about method, technique and cost; and the study's authors emphasize the need for further research and proper training before widespread adoption.

A review of 67 randomized trials of antioxidant supplements has found no evidence that they prolong life, and strong evidence that they might shorten it. The trials included almost a quarter-million participants, including healthy people and those with various diseases. Over all, the authors of the review paper found, antioxidant supplements had no effect on mortality. But in the strongest studies (19 double-blind trials with good randomization and follow-up), supplements in doses considerably larger than those in typical multivitamin pills appeared to increase the risk of death, by 16 percent for vitamin A, 7 percent for beta carotene, and 4 percent for vitamin E. It made no difference whether the groups tested were healthy or ill. Vitamin C and selenium, on the other hand, had no discernible effect. [ABSTRACT FROM PUBLISHER]

The article discusses the use of randomized control trials (RCTs) by researchers in the field of development economics to find cures for poverty. Topics discussed include the work of the Abdul Katif Jameel Poverty Action Lab (J-PAL) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, international aid to poor countries, and the work of Michael Kremer, a development economist.